Works matching IS 13518216 AND DT 2019 AND VI 25 AND IP 4
Results: 42
Healthcare professionals in the 'tainted blood' era in Canada: Their forgotten emotions.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. 651, doi. 10.1111/hae.13805
- By:
- Publication type:
- Article
Phenotypic characterization of haemophilia B – Understanding the underlying biology of coagulation factor IX.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. 567, doi. 10.1111/hae.13804
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. 718, doi. 10.1111/hae.13832
- Publication type:
- Article
Recurrent and novel disease‐causing F8 variants in boys with severe haemophilia A in Poland.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. e311, doi. 10.1111/hae.13784
- By:
- Publication type:
- Article
An update on the new classification of Ehlers‐Danlos syndrome and review of the causes of bleeding in this population.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. 558, doi. 10.1111/hae.13800
- By:
- Publication type:
- Article
Postmarketing safety and effectiveness of recombinant factor IX (nonacog alfa) in Japanese patients with haemophilia B.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. e247, doi. 10.1111/hae.13783
- By:
- Publication type:
- Article
Importance of platelet activation in the regulation of whole blood coagulation in the presence of a factor V inhibitor.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. e307, doi. 10.1111/hae.13782
- By:
- Publication type:
- Article
Vaccination in patients with haemophilia—Results from an online survey among haemophilia treatment centres in Germany.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. e304, doi. 10.1111/hae.13781
- By:
- Publication type:
- Article
VWF‐FVIII concentrates in the treatment of inherited von Willebrand disease: A single‐centre retrospective study.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. e300, doi. 10.1111/hae.13779
- By:
- Publication type:
- Article
Considering the benefits of newborn screening for haemophilia.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. e298, doi. 10.1111/hae.13776
- By:
- Publication type:
- Article
Haemophilia Experiences, Results and Opportunities (HERO study) in Brazil: Assessment of the psychosocial effects of haemophilia in patients and caregivers.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. 640, doi. 10.1111/hae.13774
- By:
- Publication type:
- Article
Physical activity and its related factors in Japanese people with haemophilia.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. e267, doi. 10.1111/hae.13773
- By:
- Publication type:
- Article
The national blueprint for 21st century data and specimen collection and observational cohort studies: NHLBI State of the Science Workshop on factor VIII inhibitors.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. 590, doi. 10.1111/hae.13772
- By:
- Publication type:
- Article
Comparison of the efficacy and safety of 12‐month low‐dose factor VIII tertiary prophylaxis vs on‐demand treatment in severe haemophilia A children.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. 633, doi. 10.1111/hae.13770
- By:
- Publication type:
- Article
Beyond the bleeding rates‐ HEAD‐US joint assessment in patients treated by late prophylaxis.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. e294, doi. 10.1111/hae.13771
- By:
- Publication type:
- Article
How to discuss gene therapy for haemophilia? A patient and physician perspective.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. 545, doi. 10.1111/hae.13769
- By:
- Publication type:
- Article
Optimizing patient flow in a multidisciplinary haemophilia clinic using quality improvement methodology.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. 626, doi. 10.1111/hae.13768
- By:
- Publication type:
- Article
Clinical Pharmacology Review of Plasma‐derived and Recombinant Protein Products: CBER Experience and Perspectives on Model‐Informed Drug Development.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. e240, doi. 10.1111/hae.13767
- By:
- Publication type:
- Article
UK vs US physician decision‐making in the treatment of haemophilia.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. 616, doi. 10.1111/hae.13766
- By:
- Publication type:
- Article
Estimation of Nuwiq<sup>®</sup> (simoctocog alfa) activity using one‐stage and chromogenic assays—Results from an international comparative field study.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. 708, doi. 10.1111/hae.13763
- By:
- Publication type:
- Article
The effects of six‐week resistance, aerobic and combined exercises on the pro‐inflammatory and anti‐inflammatory markers in overweight patients with moderate haemophilia A: A randomized controlled trial.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. e257, doi. 10.1111/hae.13764
- By:
- Publication type:
- Article
Intravenous immunoglobulin treatment in a type 3 von Willebrand disease patient with alloantibodies and a life‐threatening gastrointestinal bleed.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. e291, doi. 10.1111/hae.13765
- By:
- Publication type:
- Article
Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. 656, doi. 10.1111/hae.13756
- By:
- Publication type:
- Article
The changing face of immune tolerance induction in haemophilia A with the advent of emicizumab.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. 676, doi. 10.1111/hae.13762
- By:
- Publication type:
- Article
Missense changes in the catalytic domain of coagulation factor X account for minimal function preventing a perinatal lethal condition.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. 685, doi. 10.1111/hae.13761
- By:
- Publication type:
- Article
Translation, validation and reliability of the functional capacity questionnaire Haemophilia Activities List for haemophilia patients in Brazil.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. e231, doi. 10.1111/hae.13760
- By:
- Publication type:
- Article
Extreme skewing of X‐inactivation: Rethinking severe haemophilia in women and girls.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. e286, doi. 10.1111/hae.13755
- By:
- Publication type:
- Article
Regional variation and cost implications of prescribed extended half‐life factor concentrates among U.S. Haemophilia Treatment Centres for patients with moderate and severe haemophilia.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. 668, doi. 10.1111/hae.13758
- By:
- Publication type:
- Article
The role of an accurate diagnosis of inherited thrombocytopenia as the basis for an effective treatment. A case of MYH9 syndrome treated with a TPO‐RA.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. e288, doi. 10.1111/hae.13757
- By:
- Publication type:
- Article
Ischaemic events are rare, and the prevalence of hypertension is not high in Japanese adults with haemophilia: First multicentre study in Asia.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. e223, doi. 10.1111/hae.13749
- By:
- Publication type:
- Article
Standard and water rehabilitation: An analysis of over 14 years' experience in patients with haemophilia or other clotting factor disorders after orthopaedic surgery.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. 699, doi. 10.1111/hae.13748
- By:
- Publication type:
- Article
Prophylactic protocol for dental care in ligneous gingivitis due to severe plasminogen deficiency: Case report and review of literature.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. 693, doi. 10.1111/hae.13745
- By:
- Publication type:
- Article
Spontaneous recurrent intracranial haemorrhage in a woman with type 2B von Willebrand disease: A clinical case and a brief literature review.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. e282, doi. 10.1111/hae.13742
- By:
- Publication type:
- Article
The national blueprint for future basic and translational research to understand factor VIII immunogenicity: NHLBI State of the Science Workshop on factor VIII inhibitors.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. 595, doi. 10.1111/hae.13740
- By:
- Publication type:
- Article
Molecular analysis of eight severe FV‐deficient patients in Pakistan: A large series of homozygous for frameshift mutations.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. e278, doi. 10.1111/hae.13741
- By:
- Publication type:
- Article
The national blueprint for pregnancy/birth longitudinal cohorts to study factor VIII immunogenicity: NHLBI State of the Science (SOS) Workshop on factor VIII inhibitors.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. 603, doi. 10.1111/hae.13739
- By:
- Publication type:
- Article
Mutation characteristic of 103 haemophilia A patients in Vietnam: Identification of novel mutations.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. e274, doi. 10.1111/hae.13738
- By:
- Publication type:
- Article
Origins and organization of the NHLBI State of the Science Workshop: Generating a national blueprint for future research on factor VIII inhibitors.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. 575, doi. 10.1111/hae.13737
- By:
- Publication type:
- Article
The national blueprint for future factor VIII inhibitor clinical trials: NHLBI State of the Science (SOS) Workshop on factor VIII inhibitors.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. 581, doi. 10.1111/hae.13717
- By:
- Publication type:
- Article
Executive summary of the NHLBI State of the Science (SOS) Workshop: Overview and next steps in generating a national blueprint for future research on factor VIII inhibitors.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. 610, doi. 10.1111/hae.13713
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. 539, doi. 10.1111/hae.13578
- Publication type:
- Article
Instructions for Authors.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. 719, doi. 10.1111/hae.13577
- Publication type:
- Article